Clicky

Avacta Group Plc(AVCTF) News

Date Title
Jan 17 Avacta Therapeutics reports data from trial of AVA6000 for salivary gland cancer
Dec 30 While institutions own 41% of Avacta Group Plc (LON:AVCT), individual investors are its largest shareholders with 57% ownership
Oct 3 Avacta Group First Half 2024 Earnings: UK£0.038 loss per share (vs UK£0.043 loss in 1H 2023)
Jul 23 Avacta Group Plc's (LON:AVCT) largest shareholders are retail investors with 58% ownership, institutions own 41%
Dec 19 Appointment of Chief Business Officer
Nov 30 Levicept Appoints Eliot Forster as CEO
Sep 7 Avacta Group Plc (LON:AVCT) is largely controlled by institutional shareholders who own 53% of the company
Apr 27 First Patient Dosed in the US in Avacta’s AVA6000 Phase 1 Clinical Study